logo
PR campaign may have fuelled food study backlash, leaked document shows

PR campaign may have fuelled food study backlash, leaked document shows

The Guardian11-04-2025

A leaked document shows that vested interests may have been behind a 'mud-slinging' PR campaign to discredit a landmark environment study, according to an investigation.
The Eat-Lancet Commission study, published in 2019, set out to answer the question: how can we feed the world's growing population without causing catastrophic climate breakdown?
The report recommended that if global red meat eating was cut by 50%, the 'planetary health diet' would provide nutritious food to all while tackling the harms caused by animal agriculture, which accounts for over 14% of all greenhouse gas emissions worldwide. It suggested individuals – particularly in wealthy countries – should increase their consumption of nuts, pulses and other plant-based foods while cutting meat and sugar from their diets.
It may have seemed like a fairly straightforward proposal but the backlash was ferocious, with researchers receiving personal threats and insults. Thousands of negative posts were shared on Twitter (now X), and more than 500 articles were published criticising the report.
A leaked document seen by the climate website DeSmog reveals that helping to fuel this backlash was a PR firm, Red Flag, which represented the Animal Agriculture Alliance, a meat and dairy industry coalition set up to protect the sector against 'emerging threats', and which has staff from Cargill and Smithfield Foods – two of the world's five largest meat companies – on its board.
DeSmog has seen a document from the PR firm which states: 'In the two weeks following publication of the Eat-Lancet report, this campaign's messages have continued to demonstrate remarkable success. Key stories returned time and again in traditional and social media to reach major online influencers, particularly highlighting the radical nature of the Eat-Lancet diet and hypocrisy criticisms levelled at the Eat founders.'
As part of the campaign's impact, in the weeks following publication, the document states that nearly half of the 1,315 articles about the Eat-Lancet report included Red Flag's 'campaign messages and quotes' and adds that 103 articles mentioned alleged hypocrisy of the group's founders – 'sparking a Twitter conversation that received over 1 million more views' than the top tweets posted by Eat about the report.
Red Flag's document includes, as highlights of the campaign, an article in the UK's Spectator magazine about plans 'to change your diet by force', and a number of social media posts claiming the report was 'dangerous' and told 'poor people to eat dirt'. The PR firm's precise role in seeding or amplifying these posts, if any, is unknown.
'Targeted briefings and stakeholder activation ensured' that some framed the Eat-Lancet report, plus a subsequent report, 'as radical and out of touch'. Briefings included an 'advance press engagement' with the Institute of Economic Affairs, a UK libertarian thinktank, with hostile articles about the Eat-Lancet study quoting the group, which dismissed the report as an elitist attack on normal people.
In the year following Eat-Lancet's publication, scientists involved in it were targeted online. In some cases, the backlash led to them withdrawing from press appearances to discuss the research and undermined their academic careers. There is no suggestion that Red Flag was involved in or responsible for these threats.
One author, Dr Marco Springmann, said he faced serious burnout after the 'media storm' that went on for a year after publication. A senior researcher at the Environmental Change Institute at the University of Oxford and a professorial research fellow at the Institute for Global Health at University College London, he was repeatedly accused of bias for eating a plant-based diet.
'Usually I lead on two to three studies a year, but in the year following Eat-Lancet, I wasn't able to even lead on one,' Springmann said.
Dr Line Gordon, another author of the study, said she was 'overwhelmed' with 'really nasty' comments in the immediate aftermath of its publication, and the backlash was 'exhausting'.
'I was excited about the research we had done and how important it was and how much work we had put into it,' she said. 'However, when we launched, I remember waking up in the morning and I've never been attacked in so many ways.'
And Dr Gunhild Stordalen, the chief executive of the environmental advocacy group Eat which, alongside the Wellcome Trust, funded the research, was one of those personally targeted, along with her husband, Petter Stordalen, a Norwegian property mogul who was pictured on Instagram eating a large burger. Other articles cited the couple's high-carbon lifestyle, including owning a private jet.
A study of social media posts in the months after the report's publication, published in the Lancet journal, found opponents of the research had dominated discussions and used 'misinformation, conspiracy theories, and personal attacks' to discredit the work.
Sign up to Down to Earth
The planet's most important stories. Get all the week's environment news - the good, the bad and the essential
after newsletter promotion
'Red Flag turned Eat-Lancet into a culture-war issue,' Jennifer Jacquet, a professor of environmental science and policy at the University of Miami and an expert on lobbying, told DeSmog. 'Instead of having nuanced conversations about the data, Red Flag takes us back to mud slinging. This document is a portrait of what we're up against – as people who care about the truth, about climate change, and about the future.'
Experts told DeSmog that the online backlash was one of the earliest examples of a culture war around dietary change that had become well-recognised in more recent years.
Victor Galaz, an associate professor at the Stockholm Resilience Center, Stockholm University, which was involved in shaping the Eat-Lancet report, studied the online response at the time. 'Everyone was shocked by the volume and tone of the tweets: the aggressiveness and degree of lying, to put it very bluntly,' he said. 'Climate change science has faced this kind of backlash for a while. But in this domain – diets and meat – that was new to people. Everyone was shocked.'
The researchers behind the report were clear that they welcomed legitimate critiques of its contents – it was not without criticisms in the academic world – but online articles and social media posts often overblew or did not engage with these nuanced debates.
'We are not perfect. It's good to hear constructive criticism, that's part of academic discourse,' said Springmann. 'But if it gets into an ideological shouting match, we don't get anywhere. I don't do research to fight.'
While there is no suggestion that Red Flag was involved in personal attacks against the Eat-Lancet authors, Jacquet told DeSmog that the PR firm's campaign had likely helped to make the report so divisive.
'The industry doesn't make investments like this whimsically,' she said. 'They know that this affects the tenor of the conversation. It's a really illustrative example of how PR firms operate in the 21st century.'
Yet in spite of the online backlash the Eat-Lancet report has been one of the most influential studies of recent decades. It is among the papers most often cited by governments and in policy briefs across all topics, used in more than 600 such documents since its launch.
With the second Eat-Lancet report due out this year, Springmann, who joined the second research group despite having reservations, told DeSmog he hoped the new research could spark a more constructive conversation.
'It's a big opportunity to put the debate back on a better track,' he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Millions in west do not know they have aggressive fatty liver disease, study says
Millions in west do not know they have aggressive fatty liver disease, study says

The Guardian

timea day ago

  • The Guardian

Millions in west do not know they have aggressive fatty liver disease, study says

More than 15 million people in the US, UK, Germany and France do not know they have the most aggressive form of fatty liver disease, according to research. Metabolic dysfunction-associated steatotic liver disease (MASLD) – the formal name for non-alcoholic fatty liver disease – occurs in people who drink no or minimal amounts of alcohol whose liver contains more than 5% fat. Around two-thirds of patients with type 2 diabetes are thought to have the condition, which is also associated with obesity, heart and circulatory disease. Around 5% of adults globally have the most aggressive form of MASLD. Metabolic dysfunction-associated steatohepatitis (MASH) causes fibrosis (scarring) and can lead to cirrhosis and is linked to greater risk of cardiovascular disease, chronic kidney disease and liver cancer. But the vast majority of people do not know they have the condition. An international group of researchers examined prevalence and diagnosis of aggressive fatty liver disease in the US, UK, Germany and France. The researchers found that just under 3% of people in the UK, France and Germany, and 4% of those in the US have MASH, but diagnosis rates were below 18%. That means about 20 million people in the US, UK, Germany and France are living with MASH but only 2.5 million people have a diagnosis, leaving more than three-quarters – about 16.7 million people – unaware they have the condition. The report, published in the Lancet Regional Health Europe and presented at an the meeting of the global thinktank on steatotic liver disease in Barcelona, Spain on Thursday, calls for a doubling in diagnosis rates from 2022 levels. Traditionally, MASH was diagnosed through biopsy, but now non-invasive methods, such as blood tests, ultrasound and MRI scans can be used. As a result, everyone with type 2 diabetes; obesity combined with one or more other risk factors; and those with persistently high liver enzymes should be screened for MASH, the researchers conclude. Dr Jeffrey Lazarus, the lead author of the paper and a professor of global health in New York and Barcelona, said: 'Undiagnosed MASH costs economies billions of pounds in lost productivity and poor health. Unless diagnosis rates are doubled, alongside similar increases in treatment and care, direct health costs alone are predicted to triple over the next 20 years.' Responding to the findings, Emmanouil Tsochatzis, a professor of hepatology at UCL and a consultant hepatologist at the Royal Free hospital, said: 'More than 15 million people across the US and Europe have the deadliest form of fatty liver disease – and don't know it. Without faster diagnosis and access to treatment, the human and economic toll will skyrocket.' The research has also prompted renewed calls for weight loss jabs to be used to treat MASH. Dr Paul Brennan, a co-author of the Lancet paper and a hepatologist at NHS Tayside, said: 'GLP-1s (including Wegovy and Mounjaro) offer the potential to resynchronise our metabolism, by introducing feelings of satiety – fullness – and delaying the time the stomach takes to empty. These effects often result in reduced calorie intake, and improvements in how the liver handles nutrients as a result of weight loss, thus reducing scar tissue formation in the liver.' Michael Betel, the president of the Fatty Liver Alliance, said: 'Too many people living with type 2 diabetes or obesity are never tested for MASH until it's too late. We need a huge increase in liver health assessments in patients living with these diseases, alongside lifestyle changes and for some, when appropriate, weight loss drugs to reduce blood sugar and appetite. While weight loss drugs weren't created to treat liver disease, trials suggest they could benefit multiple metabolic-related conditions, and improve our liver health.' Separately a study published on Wednesday found that the diabetes drug dapagliflozin, which reduces blood sugar levels, can also reduce fat levels and fibrosis in the liver.

Innovative treatment effective in patients with certain tumours, study suggests
Innovative treatment effective in patients with certain tumours, study suggests

The Independent

time6 days ago

  • The Independent

Innovative treatment effective in patients with certain tumours, study suggests

An innovative treatment that reprogrammes immune cells to recognise and kill cancer has been shown to be effective on patients with certain tumours in a pioneering trial. CAR T-cell therapy is usually used to treat some types of blood cancer. It involves genetically modifying a patient's T cells – a type of white blood cell – in a lab, before returning them to the bloodstream. A new first of its kind trial explored the use of the treatment in patients with advanced stomach cancer and gastroesophageal junction (GEJ) cancer, which develops at the point where the oesophagus meets the stomach. The phase two study, led by researchers in China, included people diagnosed with advanced stomach or GEJ cancer which had not responded to two previous lines of treatment. Some 104 patients were earmarked for CAR T-cell therapy while 52 were given standard care, which included a selection of drugs chosen by their doctor. Those who had CAR T-cell therapy lived an average for 7.9 months, compared to 5.5 months with standard care. Patients who received the treatment also spent 3.3 months without their cancer progressing compared to 1.8 months in the standard group. Researchers said that the study is the 'first randomised controlled trial of CAR T-cell therapy in solid tumours globally' and shows the treatment 'resulted in a significant improvement in progression-free survival, with a manageable safety profile'. They added that the findings, published in the Lancet and presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, support CAR T-cell therapy 'as a new third-line treatment' for patients with advanced stomach and GEJ cancer.

Parental intuition better at spotting child illness than vital signs, study finds
Parental intuition better at spotting child illness than vital signs, study finds

The Guardian

time30-05-2025

  • The Guardian

Parental intuition better at spotting child illness than vital signs, study finds

Parental intuition is more likely to predict critical illness among children than vital signs used to monitor health, according to a study that strengthens the case for families to have a right to a second opinion under Martha's rule being piloted in the NHS. Experts from Monash University in Melbourne, Australia, said parents should be treated as part of a child's care team in hospital after data on almost 190,000 emergency hospital visits involving children. The researchers found that prenatal concern was associated with a higher likelihood the child would need to be given help to breathe, or mechanical ventilation. The research, published in the Lancet's journal on Child and Adolescent Health, noted that in almost one in five cases (19.3%) parents raised concerns about deterioration before vital signs indicated that the child was deteriorating. It comes after the tragic case of Martha Mills, who developed sepsis after an injuring her pancreas when she fell off her bike. She died in 2021 when doctors ignored repeatedly the concerns of her parents about her deterioration while in hospital. A coroner ruled she would most likely have survived if doctors had identified the warning signs of her rapidly deteriorating condition and transferred her to intensive care earlier. A campaign by Martha's mother, Merope Mills, an editor at the Guardian, and her father, Paul Laity, led NHS hospitals to pilot Martha's rule, which gives patients and their loved ones the right to an urgent review of treatment. Last December, NHS England data showed the rule was having a 'transformative effect' in improving patient safety. In the Melbourne study, parents and carers were routinely asked: 'Are you worried your child is getting worse?' In 4.7% of cases parents said they were concerned their child was deteriorating. The research team found that parents' and carers' concerns were 'significantly' linked to the child being admitted to an intensive care unit (ICU). When parents raised concerns, children were four times more likely to need ICU care, compared with children of parents who did not express concern. They also found that parental concern was more strongly associated with ICU admission than abnormal vital signs were – including abnormal heart rate, abnormal breathing or blood pressure. This could mean that taking parents' views into account could lead to earlier treatment, they added. Overall, they found that children of caregivers who voiced concerns were 'more unwell, they were more likely to be admitted to an inpatient ward, and stayed in hospital almost three times as long'. One of the lead authors of the paper, Dr Erin Mills, from Monash University's School of Clinical Sciences at Monash Health, said: 'We know that parents are the experts in their children, but stories of parents not being heard, followed by devastating outcomes, are all too common. We wanted to change that.' She added: 'If a parent said they were worried, their child was around four times more likely to require intensive care. That's a signal we can't afford to ignore. 'Parents are not visitors – they are part of the care team. We want every hospital to recognise that and give parents permission, and power, to speak up.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store